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Abstract. 
 
Mitosis in human cells is initiated by the pro-
tein kinase Cdc2-cyclin B1, which is activated at the end 
of G2 by dephosphorylation of two inhibitory residues, 
Thr14 and Tyr15. The G2 arrest that occurs after DNA 
damage is due in part to stabilization of phosphoryla-
tion at these sites. We explored the possibility that en-
try into mitosis is also regulated by the subcellular loca-
tion of Cdc2-cyclin B1, which is suddenly imported into 
the nucleus at the end of G2. We measured the timing 
of mitosis in HeLa cells expressing a constitutively nu-
clear cyclin B1 mutant. Parallel studies were performed 
with cells expressing Cdc2AF, a Cdc2 mutant that can-
not be phosphorylated at inhibitory sites. Whereas nu-
clear cyclin B1 and Cdc2AF each had little effect under 
normal growth conditions, together they induced a 
striking premature mitotic phenotype. Nuclear target-
ing of cyclin B1 was particularly effective in cells ar-
rested in G2 by DNA damage, where it greatly reduced 
the damage-induced G2 arrest. Expression of nuclear 
cyclin B1 and Cdc2AF also resulted in significant de-
fects in the exit from mitosis. Thus, nuclear targeting of 
cyclin B1 and dephosphorylation of Cdc2 both contrib-
ute to the control of mitotic entry and exit in human 
cells.
 
I
 
nitiation
 
 of mitosis in human cells is triggered by
abrupt activation of the cyclin-dependent protein ki-
nase Cdc2 (or Cdk1; for reviews see Nurse, 1990;
Dunphy, 1994; King et al., 1994; Lew and Kornbluth, 1996;
Morgan, 1997). Activation of Cdc2 is a complex process
that begins when the Cdc2 catalytic subunit associates with
its regulatory subunit, cyclin B1, whose levels rise during S
phase and G2, and peak in mitosis. Before mitosis, the ex-
panding population of Cdc2-cyclin B1 complexes is held in
an inactive state by Cdc2 phosphorylation at Thr14 and
Tyr15. These phosphorylations are catalyzed by Wee1,
Myt1, and related protein kinases; dephosphorylation is
catalyzed by the phosphatase Cdc25C.
At the end of G2, sudden dephosphorylation of inhibi-
tory sites on Cdc2 leads to complete activation of the
Cdc2-cyclin B1 stockpile. Rapid dephosphorylation of Cdc2
is thought to result from simultaneous inactivation of Wee1-
like kinases and activation of the phosphatase Cdc25C.
Mitotic changes in Wee1 and Cdc25C activity are due in
part to their phosphorylation by Cdc2-cyclin B1, suggest-
ing that positive feedback loops help generate the rapid
activation of Cdc2-cyclin B1 complexes (for reviews see
Dunphy, 1994; Lew and Kornbluth, 1996; Morgan, 1997).
Additional mechanisms also control Cdc2 dephosphoryla-
tion; for example, the protein kinase Plx phosphorylates
Cdc25C in mitosis (Kumagai and Dunphy, 1996), provid-
ing a mechanism by which other regulatory systems may
influence the onset of mitosis.
Although dephosphorylation of inhibitory sites in Cdc2
is clearly a key determinant of mitotic timing in the fission
yeast 
 
Schizosaccharomyces pombe
 
 (Gould and Nurse,
1989) and in the early 
 
Drosophila
 
 embryo (Edgar and
O’Farrell, 1989; Edgar and O’Farrell, 1990), the onset of
mitosis in mammalian cells is not controlled by this mecha-
nism alone. This issue has been addressed primarily by
studies of mitotic timing in mammalian cells expressing
Cdc2AF, a dominant mutant form of Cdc2 in which Thr14
and Tyr15 are changed to alanine and phenylalanine, re-
spectively. The Cdc2AF protein induces limited prema-
ture mitotic events when transiently overexpressed in
mammalian cells (Krek and Nigg, 1991; Heald et al., 1993).
The expression of Cdc2AF at normal levels using a tetra-
cyclin-repressible promoter in stable HeLa cell lines has
only minor effects on the timing of mitosis (Jin et al.,
1996), although long-term expression of Cdc2AF de-
creases cell viability (Jin et al., 1996; Blasina et al., 1997).
Thus, Cdc2 dephosphorylation alone is insufficient to trig-
ger mitosis in mammalian cells.
Similar evidence has been obtained in studies of mitotic
timing after DNA damage. Cell cycle checkpoint mecha-
nisms delay mitosis when a cell suffers DNA damage in S
phase or G2 (Elledge, 1996; Lydall and Weinert, 1996),
 
Address all correspondence to David Morgan, Department of Physiology,
Box 0444, University of California, San Francisco, CA 94143-0444. Tel.:
415-476-6695; Fax: 415-476-4929; E-mail: dmorgan@socrates.ucsf.edu
  
The Journal of Cell Biology, Volume 141, 1998 876
 
and there is clear evidence that this delay is caused by the
stabilization of inhibitory Cdc2 phosphorylation in 
 
S.
pombe
 
 and 
 
Aspergillus nidulans
 
 (Furnari et al., 1997;
Rhind et al., 1997; Ye et al., 1997). In mammalian cells,
Cdc2 is phosphorylated at the inhibitory sites after DNA
damage (Hofmann et al., 1994; Kharbanda et al., 1994;
O’Connor et al., 1994; Herzinger et al., 1995; Paules et al.,
1995; Poon et al., 1996), and expression of Cdc2AF re-
duces the damage-induced arrest in HeLa cells (Jin et al.,
1996) and increases radiation sensitivity (Blasina et al.,
1997), indicating that inhibitory phosphorylation helps to
delay mitosis in these cells. Recent studies suggest that
DNA damage in human cells leads to activation of a pro-
tein kinase, Chk1, that phosphorylates and inhibits the
function of Cdc25C (Peng et al., 1997; Sanchez et al., 1997;
Weinert, 1997). However, this mechanism does not ac-
count fully for the G2 arrest that occurs after DNA dam-
age. Damaged cells expressing Cdc2AF exhibit a reduced
but still considerable G2 arrest. Most importantly, Cdc2AF-
expressing cells delayed in G2 by DNA damage contain
near-maximal cyclin B1 concentrations and high levels of
Cdc2-cyclin B1-associated kinase activity (Jin et al., 1996).
Additional mechanisms must restrain mitosis in these cells
despite the presence of active Cdc2-cyclin B1 complexes.
What other mechanisms might control mitotic entry?
One possibility is supported by evidence from human cells
and starfish oocytes that the initiation of mitosis is accom-
panied not just by Cdc2 dephosphorylation, but by
changes in the subcellular location of cyclin B1 (Pines and
Hunter, 1991; Bailly et al., 1992; Gallant and Nigg, 1992;
Ookata et al., 1992; Gallant et al., 1995). During S phase
and G2, cyclin B1 accumulates in the cytoplasm. Just be-
fore mitosis, the majority of the cyclin B1-Cdc2 complexes
are suddenly found in the nucleus, remaining there until
nuclear envelope breakdown at prometaphase. As many
of the key substrates for Cdc2-cyclin B1 are in the nucleus,
its exclusion from this organelle may provide a mechanism
to limit its effects before mitosis. Indeed, Heald et al.
(1993) engineered cells containing abundant quantities of
dephosphorylated active Cdc2 whose activity was re-
stricted to the cytoplasm, and found that these active com-
plexes did not induce premature mitotic events. Similarly,
Li et al. (1997) showed that the mitosis-promoting activity
of cyclin B1 in frog eggs is abolished by mutations in cyclin
B1 that prevent its localization to the nucleus. Nuclear
translocation of cyclin B1 is therefore positioned to serve
as an additional regulatory step in the control of mitotic
initiation.
The effects of Cdc2-cyclin B1 are reversed after chro-
mosome segregation in anaphase. Thus, the inactivation of
Cdc2-cyclin B1 (presumably leading to dephosphorylation
of its substrates) is required for cells to exit mitosis. Inacti-
vation of Cdc2-cyclin B1 is generally thought to occur by
ubiquitin-dependent proteolysis of cyclin B1 (for review
see King et al., 1996). Prevention of this destruction, for
example, by expression of a nondegradable mutant cyclin,
results in arrest after anaphase in cells from a variety of or-
ganisms, including mammals (Murray et al., 1989; Gallant
and Nigg, 1992; Holloway et al., 1993; Surana et al., 1993;
Rimmington et al., 1994; Sigrist et al., 1995; Yamano et al.,
1996; Wheatley et al., 1997).
In our previous work, we speculated that DNA damage
in human cells might act both by stabilizing inhibitory
phosphorylation of Cdc2 and by maintaining the cytoplas-
mic localization of cyclin B1 (Jin et al., 1996). This hypoth-
esis is supported by observations that cyclin B1 is cytoplas-
mic in cells arrested in G2 by DNA damage (Smeets et al.,
1994; P. Jin, unpublished results). In the present work we
tested this hypothesis by assessing the timing of mitosis in
cells engineered to express a mutant version of cyclin B1
that is targeted to the nucleus at all cell cycle stages. We
find that nuclear cyclin B1 partially overrides the G2 ar-
rest that occurs after DNA damage, suggesting that cyclin
B1 localization is a rate-limiting step in the initiation of
mitosis under these conditions. Our results also provide
unexpected insights into the role of cyclin B1 localization
and degradation in the exit from mitosis.
 
Materials and Methods
 
Cell Culture
 
HeLa S3 cells were maintained in DME plus 10% FCS and synchronized
at G1/S with a double thymidine block protocol. Cells were plated at 0.5 
 
3
 
10
 
6 
 
cells per 100-mm dish. After 1 d, cells were arrested in S phase by
treatment with thymidine (2 mM) for 17 h, and were then released from
the arrest by one wash in PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM
Na
 
2
 
HPO
 
4
 
, 1.4 mM KH
 
2
 
PO
 
4
 
, 0.9 mM CaCl
 
2
 
, 0.5 mM MgCl
 
2
 
, pH 7.3) and
refeeding with thymidine-free medium. After 9 h, cells were subjected to a
second thymidine treatment. After 14 h, cells were washed once in PBS to
release from the G1/S block. For ionizing radiation experiments, cells
were x-irradiated at room temperature 1 h after release from G1/S arrest
with a 150 kV x-ray machine (Philips Electron Optics, Mahwah, NJ) at a
rate of 2.5 Gray/min for a total dose of 6 Gray. Dosage was somewhat
variable in different experiments, resulting in variations in the length of
the G2 arrest.
To analyze DNA content by flow cytometry, cells were trypsinized,
fixed in 70% ethanol, resuspended in PBS containing RNaseA (100 
 
m
 
g/ml)
and propidium iodide (10 
 
m
 
g/ml), and analyzed by a FACScan (Becton
Dickinson, Mountain View, CA) and Cellquest software. To visualize
condensed chromatin, ethanol-fixed cells stained with propidium iodide
were placed on glass slides and examined with a fluorescence microscope
(Nikon Inc., Melville, NY).
 
Recombinant Adenovirus Construction
 
Four repeats of a Myc epitope tag sequence (EQKLISEEDLN), preceded
by a methionine start codon and an upstream Kozak sequence (GCCGC-
CACC), were fused in frame to coding sequences of the human cyclin B1
cDNA using the NcoI site at the start codon. To construct nuclear cyclin
B1, a synthetic double-stranded DNA fragment (5
 
9
 
-CAT GGC AAC
CCC GCC GAA AAA AAA ACG CAA AGT GGA AGA TCC-3
 
9
 
) en-
coding the nuclear localization signal of SV40 Large T antigen was in-
serted in frame at the NcoI site between the Myc tag and cyclin B1 coding
sequence. Fusion of the Cdc2AF mutant cDNA to COOH-terminal he-
magglutinin (HA)
 
1
 
 epitope tag sequences has been described (Jin et al.,
1996).
Recombinant adenoviruses encoding Myc-cyclin B1, Myc-NLS-cyclin
B1, and Cdc2AF-HA were constructed by a recently described method
(Hardy et al., 1997). Each mutant cDNA was inserted downstream of a tet
operator and minimal CMV promoter (from pUHD10-3; Gossen and Bu-
jard, 1992) in a shuttle plasmid (pAdlox/Tet) carrying the 5
 
9
 
 sequences of
the adenoviral genome, including the 
 
C
 
 packaging signal but not the E1
genes; a single loxP recombination site is found 3
 
9
 
 of these sequences.
Shuttle plasmids were cotransfected into CRE8 cells (expressing Cre re-
combinase) with mutant adenovirus DNA (
 
C
 
5) in which the packaging
signal 
 
C
 
 at the 5
 
9
 
 end of the viral genome is flanked on both sides by loxP
 
1. 
 
Abbreviations used in this paper
 
: CDK, cyclin-dependent kinase; CRS,
cytoplasmic retention signal; HA, hemagglutinin; NLS, nuclear localiza-
tion signal; MOI, multiplicity of infection; PCC, premature chromatin
condensation; tTA, tetracyclin transactivator. 
Jin et al. 
 
Control of Mitosis by Nuclear Import of Cyclin B1
 
877
 
recombination sites; in addition, the E1 and E3 genes are deleted. Cre re-
combinase in the CRE8 cells catalyzes loss of the packaging signal from
 
C
 
5 viral DNA, as well as recombination of shuttle plasmid viral sequences
with the 
 
C
 
-deleted 
 
C
 
5 viral DNA, resulting in replacement of the left end
of the 
 
C
 
5 DNA with the 5
 
9
 
 viral sequences from the shuttle plasmid. The
product is a viral genome that carries a normal packaging signal as well as
the foreign cDNA under Tet control. Recombinant virus is packaged and
released from the cell, but is replication-defective because E1 genes are
deleted (Hardy et al., 1997). A recombinant adenovirus expressing the tet-
racyclin transactivator (tTA) was constructed with the tTA cDNA and up-
stream CMV promoter from pUHD15-1 (Gossen and Bujard, 1992).
Recombinant adenoviruses were plaque-purified, amplified, and ti-
tered in 293 cells. 4 h before release from the G1/S arrest, HeLa cells were
infected with the tTA virus plus the desired cyclin B1 or Cdc2AF virus or
viruses, each at a multiplicity of infection (MOI) of 5–10 plaque-forming
units per cell. Secondary immunofluorescence with antibodies against the
Myc epitope tag revealed that 90–95% of cells in the infected population
express the foreign protein in these experiments.
 
Immunofluorescence Analysis
 
For 
 
a
 
-Myc analysis, cells growing on coverslips were rinsed with PBS,
fixed with methanol/acetone (1:1) for 5 min, and incubated for 30 min at
room temperature with 
 
a
 
-Myc monoclonal antibody (9E10 ascites fluid,
diluted 1:250). For immunostaining with 
 
a
 
-lamin A and MPM-2, cells
growing on cell culture dishes were collected by trypsinization and fixed in
3% formaldehyde/2% sucrose in PBS for 20 min. Fixed cells were centri-
fuged onto coverslips, washed with PBS, and incubated for 5 min with
PBS containing 0.5% Triton X-100. Incubations with primary antibodies,
diluted at 1:1000, were carried out for 30 min at room temperature. Mouse
monoclonal antibody against lamin A was provided by Erich Nigg (Univer-
sity of Geneva); MPM-2 monoclonal antibody was provided by Arshad
Desai (University of California, San Francisco). After five washes with PBS,
FITC-conjugated secondary antibodies were added for 30 min. Cells were
washed with PBS, incubated for 5 min with Hoechst 33258 (50 ng/ml),
mounted in 90% glycerol containing o-phenyldiamine, and examined with
a fluorescence microscope (Nikon Inc., Melville, NY).
 
Biochemical Procedures
 
To prepare cell lysates, cells were detached from dishes with a rubber po-
liceman, harvested by centrifugation, and resuspended in lysis buffer (10
mM Hepes-NaOH, pH 7.4, 10 mM NaCl, 1 mM EDTA, 0.1% Triton X-100,
50 mM NaF, 80 mM 
 
b
 
-glycerophosphate, 0.1 mM Na
 
3
 
VO
 
4
 
, 1 mM phenyl
methylsulfonyl fluoride, 1 
 
m
 
g/ml leupeptin, 20 U/ml aprotinin). Lysates
were clarified by centrifugation (10,000 
 
g 
 
for
 
 
 
10 min at 4
 
8
 
C). To measure
histone H1 kinase activity, cell lysate (25 
 
m
 
g) was incubated for 1 h at 4
 
8
 
C
with protein A-Sepharose and affinity-purified rabbit anti-cyclin B1 anti-
body (raised against baculovirus-derived and purified human cyclin B1
protein; a gift of Catherine Takizawa (University of California, San Fran-
cisco). Immunoprecipitates were washed three times with HBS (10 mM
Hepes-NaOH, pH 7.4, 150 mM NaCl) containing 0.1% Triton X-100,
twice with HBS containing 1 mM DTT, and incubated in HBS (30 
 
m
 
l) con-
taining 10 mM MgCl
 
2
 
, 50 
 
m
 
M ATP, 1 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP (3,000 mCi/mmol;
Amersham Corp., Arlington Heights, IL), 1 mM DTT, and 5 
 
m
 
g of histone
H1 (Boehringer Mannheim Corp., Indianapolis, IN). After 5 min at 24
 
8
 
C,
reaction products were analyzed by SDS-PAGE and autoradiography.
Immunoblotting was performed with ECL Western blotting detection re-
agents (Nycomed Amersham, Buckinghamshire, UK).
 
Results
 
Expression of Foreign Cyclin Proteins in HeLa
Cells with Recombinant Adenoviruses
 
To explore the role of cyclin B1 localization in mitotic tim-
ing, we used the straightforward approach of analyzing the
biological effects of forcing cyclin B1 into the nucleus be-
fore mitosis. We fused a nuclear localization signal (NLS)
from SV40 large T antigen to the amino terminus of hu-
man cyclin B1; previous studies indicate that attachment
of an NLS causes constitutive nuclear localization of cyclin
B1 (Pines and Hunter, 1994). A quadruple Myc-epitope
tag was also added to the amino terminus of the NLS-
tagged cyclin B1; a Myc-tagged wild-type cyclin B1 was
constructed for control experiments. This epitope tag al-
lowed us to assess the expression of foreign cyclin pro-
teins, and distinguish them from endogenous cyclin B1.
The amino-terminal Myc and NLS tags do not interfere
with the ability of cyclin B1 to bind and activate Cdc2
(data not shown).
Recombinant adenovirus vectors were used to tran-
siently express foreign proteins in HeLa cells. We used a
recently developed method (Hardy et al., 1997; see Mate-
rials and Methods) to construct replication-defective re-
combinant adenoviruses in which the desired cDNA is un-
der the control of a tetracyclin-repressible promoter;
expression from this promoter requires that cells are coin-
fected with a recombinant adenovirus encoding the tTA
transactivator (Gossen and Bujard, 1992). Infection with
these recombinant viruses provides a rapid method to in-
duce expression of foreign genes in almost 100% of the
cell population. Protein expression can be tightly con-
trolled in this system by varying the MOI. We used an
MOI of 5–10 pfu/cell, resulting in moderate levels of cyclin
B1 expression that were about three to fivefold higher
than normal mitotic levels.
Recombinant adenoviruses lack the E1 genes, the major
source of viral proteins known to affect the cell division
cycle (Shenk, 1996). In addition, the remaining early gene
products that affect cell division (products of the E4
genes) are not expressed until over 24 h after infection
(Hardy et al., 1989). As a result, infection with control vi-
ruses, such as the virus encoding the tTA protein, does not
result in detectable effects on cell cycle progression during
the 24-h time course of our experiments (data not shown).
 
Nuclear Cyclin Import Collaborates with Cdc2 
Dephosphorylation to Control Mitotic Entry
 
We first established the effects of NLS-tagged cyclin B1 on
the timing of mitosis under normal growth conditions.
HeLa cells were synchronized at the beginning of S phase
with a double thymidine block, infected with recombinant
adenoviruses for 3–4 h, and then released from the arrest.
Immunofluorescence analysis of Myc-tagged cyclin B1 in
these cells confirmed that cyclin B1 was located predomi-
nantly in the cytoplasm during S phase and G2, while the
NLS-tagged cyclin B1 was found entirely in the nucleus
(Fig. 1 
 
A
 
).
In control cells infected only with the tTA virus, mitosis
occurred 
 
z
 
8–12 h after release from the G1/S block, as in-
dicated by flow cytometric analysis of DNA content (Fig. 1
 
C
 
, 
 
a
 
) and analysis of chromosome condensation by fluo-
rescence microscopy of cells stained with propidium io-
dide (Fig. 1 
 
D
 
). Uninfected HeLa cells displayed essen-
tially identical behavior (data not shown). Biochemical
analysis of lysates of control cells (Fig. 1 
 
B
 
, 
 
a
 
) confirmed
that cyclin B1 protein and associated kinase activity
peaked at 8 h. Immunoblotting of Cdc2 revealed that a
fraction of Cdc2 exhibited the decreased gel mobility that
is known to be caused by phosphorylation of Thr14 and
Tyr15 (Norbury et al., 1991; Solomon et al., 1992); this
shift disappeared as cells progressed through mitosis. 
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Figure 1. Effects of nuclear cyclin B1 and Cdc2AF on progression through mitosis. (A) HeLa cells were synchronized at the G1/S
boundary by a double thymidine treatment and infected for 3 h with recombinant adenoviruses encoding the tTA transactivator (a and
f, control) or with multiple viruses encoding tTA plus cyclin B1 (b and g, B1), NLS-cyclin B1 (c and h, NB1), both cyclin B1 and Cdc2AF
(d and i, B1 1 AF), or both NLS-cyclin B1 and Cdc2AF (e and j; NB1 1 AF). 4 h after release from G1/S arrest, cells were subjected to
secondary immunofluorescence analysis with an antibody against the Myc epitope tag on cyclin B1 (a-Myc; a–e) and treated with Hoechst
33258 to label nuclear DNA (f–j). (B) HeLa cells were synchronized at the G1/S boundary and infected for 4 h with recombinant aden-
oviruses encoding the tTA transactivator (a, Control) or with multiple viruses encoding tTA plus cyclin B1 (b, B1), NLS-cyclin B1 (c,
N.B1), Cdc2AF (d, AF), both cyclin B1 and Cdc2AF (e, B1 1 AF), or both NLS-cyclin B1 and Cdc2AF (f, N.B1 1 AF). Cell lysates pre-
pared at the indicated times after G1/S release were subjected to immunoblotting with antibodies against cyclin B1 (left), or antibodies
against the PSTAIRE sequence conserved among CDKs (middle; Cdc2 is the major anti-PSTAIRE antigen in HeLa cells). Arrowheads
indicate the epitope-tagged, virally-encoded cyclin B1, NLS-cyclin B1, and Cdc2AF proteins. Histone H1 kinase activity was measured in
immunoprecipitates with anti-cyclin B1 (right); autoradiographic exposure times were 1.5 h. (C) Cells from the same experiment as in B
were harvested at the indicated times, fixed, stained with propidium iodide, and analyzed by flow cytometry to measure DNA content.
Abbreviations are as given in B. (D) A fraction of the cells prepared for flow cytometric analysis in C were examined by microscopy for
the presence of condensed chromosomes. At least 300 cells were analyzed for each sample. These values represent the means of data ob-
tained from two separate experiments, in which results were essentially identical. Abbreviations are as given in B. 
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Expression of Cdc2AF, tagged at its COOH terminus
with an HA epitope tag, induced moderate effects similar
to those observed in our previous studies (Jin et al., 1996):
low levels of premature chromosome condensation (PCC)
were observed 4 h after release from G1/S (Fig. 1 
 
D
 
), and
DNA content analysis revealed a small fraction of cells
that progressed prematurely into G1 (Fig. 1 
 
C
 
, 
 
d
 
). Cdc2
dephosphorylation and cyclin degradation also occurred
slightly earlier than in control cells (Fig. 1 
 
B
 
, 
 
d
 
).
Expression of cyclin B1 or NLS-tagged cyclin B1 had no
significant effects on the timing of mitotic entry (mitotic
exit will be discussed below). In both cases, PCC was not
observed, and mitosis in the majority of cells occurred at
about the same time as in control cells (Fig. 1, 
 
C
 
 and 
 
D
 
).
Cyclin-associated kinase activity was higher in these cells
than in control cells, but still rose to a peak at the 8-h time
point (Fig. 1 
 
B
 
). Inhibitory phosphorylation of Cdc2 was
also increased, presumably due to increased cyclin levels
(Cdc2 phosphorylation is cyclin-dependent; Solomon et
al., 1990). We conclude that nuclear localization of cyclin
B1 alone is insufficient to trigger premature mitotic events
under these conditions.
We speculated that nuclear cyclin B1 might be pre-
vented from inducing mitotic events because the Cdc2–cyclin
B1 complex is phosphorylated by Wee1 in the nucleus, as
suggested by previous work (Heald et al., 1993). Consis-
tent with this hypothesis, we found that coexpression of
nuclear cyclin B1 and Cdc2AF induced PCC in over half
of the population only 4 h after release from the G1/S
block (Fig. 1 
 
D
 
). These effects are particularly noteworthy
because the level of Cdc2AF protein expressed at early
time points in these experiments was very low; coinfection
tended to reduce expression of both proteins (Fig. 1 
 
B
 
, 
 
f
 
).
Coexpression of Cdc2AF and wild-type cyclin B1 had
moderate effects on mitotic timing: PCC occurred in about
25% of cells 4 h after G1/S release (Fig. 1 
 
D
 
).
Premature mitotic events in coinfected cells were ac-
companied by premature activation of Cdc2-cyclin B1
complexes (Fig. 1 
 
B
 
; compare H1 kinase activities in 
 
a
 
 and
 
f
 
 at the 2- or 4-h time points). The premature activation of
Cdc2 by nuclear cyclin B1 in cells expressing barely detect-
able Cdc2AF suggests that the association of nuclear cy-
clin B1 with a very low level of Cdc2AF can trigger the
complex process leading to Cdc2 dephosphorylation.
 
Mechanisms Controlling Exit from Mitosis
 
Although our original goal in this work was to explore
mechanisms controlling entry into mitosis, our results also
provide new insights into mechanisms controlling mitotic
exit. In particular, we were surprised to find that cells ex-
pressing cyclin B1 or NLS-tagged cyclin B1 appeared to be
exiting mitosis (Fig. 1, 
 
C
 
 and 
 
D
 
) despite the fact that the
exogenous Myc-tagged cyclin B1 in these cells was only
partially degraded (Fig. 1 B, b and c). At first glance, this
result does not appear consistent with the abundant previ-
ous evidence indicating that cyclin B1 destruction is re-
quired for exit from mitosis.
To explore the mechanisms of mitotic exit in cells ex-
pressing cyclin B1, we first asked why the exogenous cyclin
B1 was not completely destroyed in late mitosis. Myc-
tagged cyclin B1 proteins were expressed at high levels in
insect cells with recombinant baculoviruses, and were added
to mitotic (cytostatic factor–arrested) extracts of Xenopus
laevis eggs that were then induced to exit from mitosis. We
found that the half-lives of Myc- and Myc/NLS-tagged cy-
clin B1 proteins were both about 10-fold greater than the
half-life of untagged human cyclin B1, although both were
significantly less stable than a mutant cyclin B1 lacking its
ubiquitin-targeting destruction box sequences (data not
shown). Thus, the amino-terminal Myc epitope tag inter-
feres partially with mitotic cyclin destruction.
How are cells exiting mitosis in the presence of abun-
dant quantities of cyclin B1? One potential explanation
was provided by immunoblotting analysis of endogenous
Cdc2 in these experiments. Whereas Cdc2 was fully de-
phosphorylated in control cells passing through mitosis
(Fig. 1 B, a), a major fraction of Cdc2 remained phosphor-
ylated in cells exiting mitosis in the presence of exogenous
cyclin B1 (Fig. 1 B, b and c). This evidence suggests that
inhibitory Cdc2 phosphorylation contributes to the inacti-
vation of Cdc2 in these cells (however, Cdc2 phosphor-
ylation cannot be the sole mechanism allowing exit from
mitosis, as Cdc2 activity declines only partially after mito-
sis, as discussed below).
If inhibitory phosphorylation helps to inactivate Cdc2 in
cells expressing cyclin B1, then cells coexpressing cyclin
B1 and Cdc2AF should exhibit defects in the exit from mi-
tosis. Results from our coinfection experiments are consis-
tent with this possibility. Analysis of chromosome con-
densation in cells coexpressing cyclin B1 and Cdc2AF
indicated that a significant fraction of these cells (gener-
ally 40–50% in different experiments) did not exit mitosis,
but remained in a mitotic state with condensed chromo-
somes (Figs. 1 D and Fig. 2). Cells in this prolonged mito-
sis did not contain intact nuclear envelopes, and contained
abundant quantities of MPM-2 antigens, which are gener-
ally thought to represent mitotic phosphoproteins (Fig. 2).
Thus, a large fraction of coinfected cells were arrested in a
mitotic state, which is consistent with the notion that mi-
totic exit is defective when both cyclin degradation and in-
hibitory phosphorylation are reduced.
Chromosomes in coinfected cells displayed the abnor-
mal clumped morphology that occurs when partial con-
densation occurs at inappropriate cell cycle stages (Fig. 2).
This morphology is distinct from the chromatin compac-
tion that occurs in cells undergoing apoptosis. We mea-
sured the extent of programmed cell death in cells coex-
pressing Cdc2AF and cyclin B1 by immunocytochemical
detection of the abundant DNA ends that are generated
during apoptosis. Apoptotic nuclei were observed in z10%
of cells 24 h after coinfection, when 50% of cells exhibited
PCC; at 48 h after infection, when all cells displayed PCC,
z35% of cells were apoptotic (data not shown). We there-
fore conclude that programmed cell death eventually fol-
lows and is perhaps a consequence of premature mitotic
events or mitotic arrest.
It seems unlikely that the mitotic arrest we observe in
coinfected cells is due to activation of the spindle assembly
checkpoint (Elledge, 1996; Rudner and Murray, 1996),
which might be expected to arrest cells in metaphase in re-
sponse to defects in the attachment of abnormally con-
densed chromosomes to the mitotic spindle. Unlike the
mitotic arrest that accompanies spindle damage, the mi-The Journal of Cell Biology, Volume 141, 1998 880
totic arrest in our experiments is accompanied by degrada-
tion of the endogenous cyclin B1 protein, indicating that
the cyclin destruction machinery has been activated. Nev-
ertheless, the possibility remains that premature chromo-
some condensation results in damage that blocks mitotic
exit through some as yet undefined mechanism. We at-
tempted to rule out this possibility by testing the effects of
Cdc2AF and cyclin B1 on mitotic exit in cells that were
first arrested in mitosis with a microtubule drug (nocoda-
zole). Despite repeated attempts with a wide range of
MOIs, we were unable to obtain significant foreign protein
expression in cells arrested in mitosis.
Postmitotic kinase activity in cells expressing wild-type
cyclin B1 does not decline as rapidly or as far as it does in
control cells (Fig. 1 B, b), suggesting that mechanisms in
addition to inhibitory Cdc2 phosphorylation must contrib-
ute to mitotic exit in these cells. Exclusion of cyclin B1
from the nucleus may be such a mechanism. Cells express-
ing NLS-tagged cyclin B1 consistently displayed a partial
defect in the exit from mitosis: z20% of these cells re-
mained arrested with condensed chromosomes (Fig. 1 D).
Cells coexpressing nuclear cyclin B1 and Cdc2AF were al-
most completely arrested in a mitotic state (Fig. 1 D) that
was always accompanied by nuclear envelope breakdown
(data not shown). Cyclin B1-associated kinase activity also
remained at high levels in these cells (Fig. 1 B, c and f).
Thus, under conditions where cyclin degradation is com-
promised, exclusion of cyclin B1 from the newly forming
nucleus may be required for efficient inactivation of Cdc2
and to prevent rapid reentry into mitosis.
Nuclear Targeting of Cyclin B1 Controls Mitotic Entry 
After DNA Damage
We next addressed our hypothesis that DNA damage acts
in part by maintaining the cytoplasmic localization of cy-
clin B1. HeLa cells were arrested at the G1/S boundary,
infected with various recombinant adenovirus vectors, and
released from the arrest. 1 h after release, cells were irradi-
ated with 6 Gray of x rays to induce DNA damage. Under
these conditions, control cells exhibited a G2 arrest of
variable length, and then began passing asynchronously
into mitosis z16 h after release from G1/S (Fig. 3, B–D).
Cdc2 was phosphorylated at inhibitory sites during the
damage-induced arrest (Fig. 3 A). Because the passage
through mitosis was asynchronous, Cdc2 dephosphoryla-
tion and cyclin B1 degradation in the population occurred
more gradually than in unirradiated cells (compare Fig. 3
A and Fig. 1 B). Cells expressing wild-type cyclin B1 ex-
hibited a slight advancement in the onset of mitosis after
DNA damage (Fig. 3, B–D). The presence of exogenous
cyclin B1 in damaged cells was accompanied by more ex-
tensive inhibitory phosphorylation of Cdc2 (Fig. 3 A), pre-
sumably due to increased quantities of cyclin-bound Cdc2.
Expression of NLS-tagged cyclin B1 caused striking pre-
mature mitotic events after DNA damage (Fig. 3, B–D).
PCC was observed in over 25% of cells 8 h after the G1/S
release, and quickly rose to include the majority of cells
12–16 h after release (Fig. 3 D). The continued chromo-
some condensation in these cells, which was accompanied
by nuclear envelope breakdown (data not shown), sug-
gests that many of these cells were arrested in a mitotic
state. Premature Cdc2 dephosphorylation and cyclin B1
degradation also occurred in these cells (Fig. 3 A). Thus,
the damage-induced G2 delay was significantly reduced in
cells expressing nuclear cyclin B1. These cells also exhib-
ited a pronounced defect in mitotic exit.
NLS-tagged cyclin B1 tended to be expressed in these
experiments at slightly (about twofold) higher levels than
wild-type cyclin B1. To rule out the possibility that this dif-
ference in protein levels was responsible for the difference
in the effects of the two proteins, we performed additional
experiments in which the expression of wild-type cyclin B1
was doubled by increasing the multiplicity of viral infec-
Figure 2. Cells coexpressing cyclin B1 and Cdc2AF arrest with a
mitotic phenotype. HeLa cells arrested at the G1/S boundary
were infected with tTA virus alone (left, control), tTA virus plus
cyclin B1-expressing adenovirus (middle, B1), or tTA virus plus
both cyclin B1- and Cdc2AF-expressing viruses (right, B1 1 AF).
16 h after G1/S release, when control cells had entered the next
G1 (see Fig. 1), cells were subjected to secondary immunofluores-
cence analysis with antibody against nuclear lamin A (a–c) or the
MPM-2 antibody, which recognizes mitotic phosphoepitopes (g–
i). The same cells were also stained with Hoechst 33258 to reveal
chromosome morphology (d–f and j–l). At this time point, z50%
of cells coexpressing cyclin B1 and Cdc2AF display the mitotic
phenotype shown in the right panels (see Fig. 1).Jin et al. Control of Mitosis by Nuclear Import of Cyclin B1 881
Figure 3. Nuclear cyclin B1 reduces the G2
arrest after DNA damage. (A) HeLa cells
synchronized at the G1/S boundary were in-
fected with adenoviruses encoding tTA (left,
control), tTA plus cyclin B1 (middle), or tTA
plus NLS-cyclin B1 (right). 1 h after the G1/S
release, cells were x-irradiated with z6 Gray.
Cell lysates prepared at the indicated times
were subjected to immunoblotting with anti-
cyclin B1 (top) and anti-PSTAIRE antibodies
(bottom). Arrowheads indicate virally-encoded
cyclin B1 and NLS-tagged cyclin B1. I.R., ion-
izing radiation. (B) Half of the cells from the
experiment in A were subjected to flow cyto-
metric analysis of DNA content. (C) Samples
of propidium iodide–stained cells from se-
lected times points were analyzed by micros-
copy and photographed to illustrate the pre-
mature chromosome condensation morphology
in cells expressing NLS-tagged cyclin B1. (D)
Percentage of cells with premature chromo-
some condensation was determined by count-
ing at least 300 cells for each sample. (E) A
separate experiment was performed in which
the microtubule-destabilizing drug nocoda-
zole was added to the cell culture medium af-
ter the G1/S release; this results in accumula-
tion of all cells in mitosis. The percentage of
cells with premature chromosome condensation was quantitated as in D. Note that the radiation dose in this experiment was slightly
greater than that in D, resulting in a more prolonged G2 arrest in control cells.The Journal of Cell Biology, Volume 141, 1998 882
tion. This increase did not lead to significant increases in
the frequency of premature mitotic events (data not shown).
The timing of mitosis in control and cyclin B1–express-
ing cells was difficult to evaluate in these experiments be-
cause of their asynchronous passage through mitosis, and
because they did not accumulate in a mitotic state like the
nuclear cyclin B1–expressing cells. We therefore per-
formed an additional experiment with cells released from
the G1/S arrest and irradiated in culture medium contain-
ing nocodazole (Fig. 3 E) to arrest cells in the following
mitosis. In this experiment, x irradiation resulted in a more
prolonged G2 delay in control cells, and mitotic cells be-
gan to accumulate over 16 h after G1/S release. Cells ex-
pressing cyclin B1 began to enter mitosis after 12 h. As
before, expression of NLS-tagged cyclin B1 resulted in ex-
tensive premature mitotic events (Fig. 3 E).
Cdc2 Dephosphorylation and Nuclear Cyclin Import
are the Key Mechanisms Governing Mitotic Entry After 
DNA Damage
To assess the relative importance of Cdc2 dephosphoryla-
tion and nuclear cyclin import in the timing of mitosis after
DNA damage, we compared mitotic timing in damaged
cells expressing Cdc2AF and NLS-tagged cyclin B1, alone
or in combination.
In the experiment shown in Fig. 4, x-irradiated control
cells began to enter mitosis asynchronously after 12 h (Fig.
4 C). As before, expression of NLS-tagged cyclin B1 in-
duced a partial override of the damage-induced G2 delay.
In this experiment the fraction of cells with PCC rose to
50% by 16 h (Fig. 4, B and C); PCC was again accompa-
nied by Cdc2 dephosphorylation and cyclin degradation
(Fig. 4 A). Expression of Cdc2AF also resulted in partial
bypass of the damage-induced G2 arrest, as seen in our
previous work (Jin et al., 1996). Coexpression of Cdc2AF
and NLS-tagged cyclin B1 resulted in extensive premature
mitotic events (Fig. 4 C). Wild-type cyclin B1 was also very
potent in the presence of Cdc2AF, despite its minimal
effects when expressed alone. Thus, combinations of
Cdc2AF and either version of cyclin B1 induced prema-
ture mitotic events to about the same extent as they did in
cells lacking DNA damage (Fig. 1), suggesting that these
combinations are able to abolish completely the damage-
induced G2 delay. Coinfection also leads to an arrest in a
mitosis-like state with condensed chromosomes, variable
DNA content, and degraded endogenous cyclin.
Discussion
Control of Mitotic Initiation
Our results indicate that the translocation of cyclin B1
from the cytoplasm to the nucleus is a rate-limiting step in
the initiation of human mitosis, particularly under condi-
tions where inhibitory phosphorylation of Cdc2 is dis-
abled. Cdc2AF expression or nuclear cyclin B1 targeting
each have a minor effect on mitotic entry under normal
growth conditions, but together are capable of inducing
extensive premature mitotic events (Fig. 1). A simple ex-
planation for these results is that the effects of Cdc2AF
are limited by cytoplasmic localization of cyclin B1, while
the effects of nuclear cyclin B1 are limited by inhibitory
phosphorylation of Cdc2. When both protective mecha-
nisms are bypassed, mitotic catastrophe results.
In previous work, coexpression of Cdc2AF and wild-
type cyclin B1 led to premature mitotic events in asyn-
chronous cells (Heald et al., 1993). We also found that
wild-type cyclin B1 has moderate effects on the timing of
mitosis in the presence of Cdc2AF (Fig. 1), confirming
that the effects of Cdc2AF are limited by cyclin B1 con-
centrations. However, in most experiments we found that
the effects of wild-type cyclin B1 were consistently less
pronounced than those seen with NLS-tagged cyclin B1.
We therefore conclude that premature mitotic events in
our experiments are caused not simply by increased con-
centrations of cyclin B1, but also by premature nuclear lo-
calization of the protein.
Control of Mitotic Exit
Recent studies in the budding yeast Saccharomyces cerevi-
siae suggest that inhibitory phosphorylation of Cdc28, the
major CDK in this organism, can contribute to mitotic exit
under some conditions (Minshull et al., 1996). Our results
suggest that similar mechanisms may exist in human cells.
We found that cells expressing a stabilized form of cyclin
B1 were capable of exiting mitosis, and that increased
Cdc2 phosphorylation accompanied mitotic exit (Fig. 1).
Coexpression of Cdc2AF with the stabilized cyclin B1 re-
sulted in an apparent defect in the ability of cells to exit
mitosis (Figs. 1 and 2). We also observed a minor defect in
mitotic exit in cells expressing Cdc2AF alone. We con-
clude that inhibitory phosphorylation of Cdc2 may be in-
volved in the exit from mitosis under these conditions.
How do we reconcile our results with previous evidence
that nondegradable cyclin mutants induce a mitotic arrest?
One simple explanation is based on the fact that cyclin
degradation was only partially defective in our experi-
ments. Partial cyclin destruction may promote mitotic exit
by triggering secondary Cdc2 inactivation mechanisms.
For example, a partial decrease in Cdc2 activity could re-
sult in some dephosphorylation of Wee1 and Cdc25C, fur-
ther inactivating Cdc2 by phosphorylation and triggering
an autocatalytic feedback loop that enhances Cdc2 phos-
phorylation. Even in cells where cyclin degradation is nor-
mal, this auxiliary inactivation loop would be expected to
enhance the rapid switch-like behavior of Cdc2 inactivation.
We speculate that exclusion of Cdc2-cyclin B1 com-
plexes from the newly forming nucleus also contributes to
the exit from mitosis in cells expressing stabilized cyclin
B1. Prolonged chromosome condensation and nuclear en-
velope breakdown, suggesting a mitotic arrest, were ob-
served in z20% of cells expressing NLS-tagged cyclin B1
under normal conditions (Fig. 1 D) and in almost all of
these cells after DNA damage (Fig. 4 C). In cells coex-
pressing nuclear cyclin B1 and Cdc2AF, mitotic exit was
completely blocked. In these cells, partial inactivation of
Cdc2 may have initiated reformation of the nuclear enve-
lope, but the presence of active Cdc2-cyclin B1 complexes
inside the envelope forced a return to the mitotic state.
In several experiments, we found that cells with pro-
longed PCC at later time points displayed a 2n DNA con-
tent (Fig. 1 C, e and f; Fig. 3 B, c; Fig. 4 B, d–f). These cellsJin et al. Control of Mitosis by Nuclear Import of Cyclin B1 883
apparently achieved exit from mitosis, and then immedi-
ately reentered a mitotic state with condensed unrepli-
cated DNA.
Mitotic Entry after DNA Damage
Previous studies clearly suggest that the G2 arrest caused
by DNA damage in human cells involves stabilization of
the inhibitory phosphorylation sites on Cdc2. Expression
of Cdc2AF in HeLa cells reduces the damage-induced G2
delay (Jin et al., 1996; this work), and increases radiation
sensitivity (Blasina et al., 1997). The DNA damage re-
sponse in human cells probably requires the protein kinase
Chk1, which has recently been shown to phosphorylate
Cdc25C at Ser216, inhibiting its function in vivo (Peng et
al., 1997; Sanchez et al., 1997; Weinert, 1997). Inducible
expression of a Cdc25C S216A mutant partially reduces
the damage-induced cell cycle delay (Peng et al., 1997).
Thus, DNA damage appears to enhance Cdc2 phosphory-
lation by inhibiting the phosphatase Cdc25C.
Expression of Cdc2AF does not completely abolish the
G2 arrest that follows DNA damage (Jin et al., 1996; this
work); in addition, this arrest is accompanied by high lev-
els of cytoplasmic Cdc2-cyclin B1 activity (Smeets et al.,
1994; Jin et al., 1996). Thus, mechanisms in addition to
Cdc2 phosphorylation must delay mitosis after damage.
The present results raise the possibility that DNA damage
acts in part by stabilizing the cytoplasmic localization of
cyclin B1. We found that constitutive nuclear targeting of
cyclin B1 caused a significant reduction in the damage-
Figure 4. Effects of nuclear cyclin B1 and Cdc2AF on the DNA
damage response. (A) HeLa cells arrested at G1/S were infected
with recombinant adenoviruses encoding tTA (a, control) or both
tTA and the indicated proteins (b–f, abbreviated as in Fig. 1). 1 h
after release from the G1/S block, cells were x-irradiated with z6
Gray. At the indicated times, cell lysates were prepared and sub-
jected to immunoblotting with anti-cyclin B1 and anti-PSTAIRE
antibodies. Arrowheads indicate virally encoded proteins. (B)
Half of the cells from the experiment in A were fixed, stained
with propidium iodide, and subjected to flow cytometry to deter-
mine DNA content. I.R., ionizing radiation. (C) Propidium io-
dide–stained cells from the analysis in B were examined by fluo-
rescence microscopy, and the percentage of cells with premature
chromosome condensation was determined by counting at least
300 cells per sample. In a parallel experiment, analysis of Myc-
tagged cyclin localization confirmed that cyclin B1 and NLS-cyclin
B1 were cytoplasmic and nuclear, respectively, in DNA-damaged
interphase cells, either in the presence or absence of Cdc2AF
(data not shown, but results were similar to those in Fig. 1 A).The Journal of Cell Biology, Volume 141, 1998 884
induced G2 delay, and a combination of nuclear cyclin B1
and Cdc2AF in damaged cells resulted in a premature mi-
totic catastrophe similar to that seen in cells lacking damage.
As in undamaged cells, the total concentration of cyclin
B1, as well as its localization, has an impact on the DNA
damage response. Under some conditions, DNA damage
transiently reduces cyclin B1 expression in HeLa cells
(Maity et al., 1995), and damage-induced arrest is reduced
in cells overexpressing cyclin B1 (Kao et al., 1997). We
also observed a moderate reduction in the damage-
induced arrest in cells expressing wild-type cyclin B1, and
a dramatic reduction in cells coexpressing cyclin B1 and
Cdc2AF (Fig. 4 C). Nevertheless, in the absence of
Cdc2AF, the effects of NLS-tagged cyclin B1 were clearly
more extensive than those of wild-type cyclin B1.
Little is known about the relationship between Cdc2-
cyclin B1 activation and nuclear translocation. In starfish
eggs, Cdc2 activation precedes nuclear import (Ookata et al.,
1992). Similarly, careful analysis of cyclin B1 localization
in HeLa cells suggests that import occurs at about the time
or just after cytoplasmic changes in microtubule behavior
and centrosome separation (Bailly et al., 1992). Thus, it
seems likely that nuclear import in human cells either im-
mediately follows Cdc2 activation or is somehow interde-
pendent with it. Therefore, it is possible that nuclear trans-
location is simply a consequence of Cdc2 activation, and is
not a separately regulated process. This possibility is not
consistent with our observations that Cdc2AF does not
completely bypass the DNA damage arrest, and that the
damage-arrested cells contain abundant, cytoplasmic Cdc2-
cyclin B1 activity (Smeets et al., 1994; Jin et al., 1996). These
observations indicate that Cdc2 activation alone is not suf-
ficient to trigger nuclear import under these conditions, al-
though it remains possible that Cdc2 activation is required
for import to occur.
Although our results are consistent with the possibility
that DNA damage can separately regulate Cdc2 activation
and cyclin localization, proof of this possibility will require
a complete understanding of the regulatory pathways con-
trolling localization. These pathways remain mysterious.
A region near the amino terminus of cyclin B1 contains a
cytoplasmic retention signal (CRS), whose deletion results
in constitutive nuclear localization; transfer of this se-
quence to a nuclear protein results in cytoplasmic localiza-
tion (Pines and Hunter, 1994). The CRS may act during in-
terphase as a cytoplasmic anchor or a nuclear export
signal. In frog eggs, the CRS contains several mitotic phos-
phorylation sites, and mutation of these sites results in
constitutive cytoplasmic localization (Li et al., 1997), sug-
gesting that phosphorylation of the CRS during mitosis
inactivates its function, and thereby triggers nuclear trans-
location. The protein kinases that catalyze cyclin phos-
phorylation have not been identified. A complete under-
standing of mitotic entry in normal and damage-delayed
cells will require more extensive knowledge of the protein
components controlling cyclin B1 localization, their rela-
tionship to components governing Cdc2 phosphorylation,
and their regulation after DNA damage.
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